CTC
VRTX icon

Cetera Trust Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Cetera Trust Company’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4K Hold
21
– – 0.01% 297
2026
Q1 		$9.38K Hold
21
– – 0.01% 301
2025
Q4 		$9.52K Hold
21
– – 0.01% 301
2025
Q3 		$8.22K Hold
21
– – ﹤0.01% 307
2025
Q2 		$9.35K Hold
21
– – 0.01% 298
2025
Q1 		$10.2K Hold
21
– – 0.01% 290
2024
Q4 		$8.46K Hold
21
– – 0.01% 308
2024
Q3 		$9.77K Hold
21
– – 0.01% 303
2024
Q2 		$9.84K Hold
21
– – 0.01% 294
2024
Q1 		$8.78K Hold
21
– – 0.01% 309
2023
Q4 		$8.54K Buy
+21
New +$7.76K 0.01% 306

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Cetera Trust Company's VRTX Position: Q2 2026 in Review

Cetera Trust Company held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 21 shares worth $10.4K. The position accounts for 0.01% of the portfolio, ranked #297.

Cetera Trust Company first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. 1,759 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Cetera Trust Company held 21 shares of Vertex Pharmaceuticals worth $10.4K as of Q2 2026.
  • Cetera Trust Company left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.01% of Cetera Trust Company's portfolio in Q2 2026, its #297 holding.
  • Cetera Trust Company first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 1,759 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Cetera Trust Company's 13F filing for Q2 2026, filed 13 Aug 2026.